Altered lipid metabolism in preeclampsia and HELLP syndrome: Links to enhanced platelet reactivity and fetal growth

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue 5, 1999, Pages 455-462

  Wetzka, Birgit ^a   Winkler, Karl ^b   Kinner, Martina ^b   Friedrich, Isolde ^b   März, Winfried ^b   Zahradnik, Hans Peter ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NONE

Author keywords

Doppler velocimetry; HELLP syndrome; Platelets; Preeclampsia; Triglycerides

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM LESION; FEMALE; FETUS CIRCULATION; FETUS GROWTH; HELLP SYNDROME; HUMAN; HYPERCOAGULABILITY; LIPID METABOLISM; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

EID: 0033452086     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994950     Document Type: Article

References (39)

1. Davey DA, MacGillivray I. The classification and definition of hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892-898
2. Weinstein L. Preeclampsia/eclampsia with hemolysis, elevated liver enzymes and thrombocytopenia. Obstet Gynecol 1985; 66:657-660
3. Dekker GA, van Geijn HP. Endothelial dysfunction in preeclampsia. Part I: Primary prevention. Therapeutic perspectives. J Perinat Med 1996;24:99-117
4. Pritchard JA, Cunningham FG, Mason RA. Coagulation changes in eclampsia: Their frequency and pathogenesis. Am J Obstet Gynecol 1975;124:855-859
5. Robertson WB, Khong TY. Pathology of the uteroplacental bed. In: Sharp F, Symonds EM, eds. Hypertension in Pregnancy. Ithaca, NY: Perinatology Press; 1987:101-113
6. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-1204
7. Rath W, Loos W, Graeff H, Kuhn W. Das HELLP-Syndrom. Gynäkologe 1992;25:430-440
8. Stary HC. Pathologie der Atherosklerose. In: Schwandt P, Richter WO, eds. Handbuch der Fettstoffwechselstörungen. Stuttgart: Schattauer; 1995:48-64
9. Green D, Chamberlain MA, Ruth KJ, Folsom AR, Liu K. Factor VII, cholesterol and triglycerides. The CARDIA Study. Coronary Artery Risk Development in Young Adults Study. Arterioscler Thromb Vasc Biol 1997;17:51-55
10. Marckmann P, Sandstorm B, Jespersen J. The variability of and association between measures of blood coagulation, fibrinolysis and blood lipids. Atherosclerosis 1992;96:235-244
11. Cadroy Y, Lemozy S, Diquelou A, et al. Human type II hyperlipidemia enhances platelet-collagen adhesion in flowing non-anticoagulated blood. Arterioscler Thromb 1993;13:1650-1653
12. Edelberg JM, Gonzales-Gronow M, Pizzo SV. Lipoprotein(a) inhibits streptokinase mediated activation of human plasminogen. Biochemistry 1989;28:2370-2374
13. Stein JH, Rosenson RS. Lipoprotein(a) and coronary heart disease. Arch Intern Med 1997;157:1170-1176
14. Potter JM, Nestel PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 1978;133: 165-170
15. Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. Serum lipoproteins, insulin and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995;85:353-356
16. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: Pathogenic parallels to atherosclerosis. Obstet Gynecol 1997; 89:403-408
17. Gratacos E, Casals E, Sanllehy C, Cararach V, Alonso PL, Fortuny A. Variations in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet Gynaecol Scand 1996;75:896-901
18. Lorentzen B, Endersen MJ, Clausen T, Henriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregnancy 1994;13:103-109
19. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids and malondialdehyde are increased in preeclampsia, are positively correlated and decrease within 48 hours post partum. Am J Obstet Gynecol 1996;174:975-982
20. Rath W, Wieding JU, Kuhn W. Neue Erkenntnisse über hämostaseologische Veränderungen bei Gestose und HELLP-Syndrom. Geburtshilfe Frauenheilkd 1991;51:741-746
21. Sattar N, Gaw A, Packard CJ, Greer IA. Potential pathogenetic roles of aberrant lipoproteins and fatty acid metabolism in preeclampsia. Br J Obstet Gynaecol 1996;103:614-620
22. Jimenez E, Vogel M, Arabin B, Wagner G, Mirsalim P. Correlation of ultrasonographic measurement of the utero-placental and fetal blood flow with the morphological diagnosis of placental function. In: Kaufmann P, Miller RK, eds. Placental Vascularization and Blood Flow. New York: Plenum Medical Book Company; 1988:325-334
23. Lindgren FT. Preparative ultracentrifugation laboratory procedure and suggestions for lipoprotein analysis. In: Perkins EG, ed. Analysis of Lipids and Lipoproteins. Champaign, IL: American Oil Chemical Society; 1975:204-224
24. Sattar N, Greer IA, Louden J, et al. Lipoprotein subfraction changes in normal pregnancy: Threshold effect of plasma triglyceride on appearance of small, dense low density lipoproteins. J Clin Endocrinol Metab 1997;82:2483-2491
25. Halim A, Kanayama N, El Maradny E, et al. Immunohistochemical study in cases of HELLP syndrome and acute fatty liver of pregnancy. Gynecol Obstet Invest 1996;41:106-112
26. Visser W, Beckmann I, Bremer HA, Lim HL, Wallenburg HCS. Bioactive tumor necrosis factor α in preeclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol 1994;101:1081-1082
27. Lorentzen B, Endresen MJ, Hovig T, Haug E, Henriksen T. Sera from preeclamptic women increase the content of triglycerides and reduce the release of of prostacyclin in cultured endothelial cells. Thromb Res 1991;63:363-372
28. Ylikokala O, Viinikk L. The role of prostaglandins in obstetrical disorders. Baillière's Clinical Obstetrics and Gynecology 1992;6: 809-827
29. Barbir M, Wile D, Trayner I, Aber VR, Thompson GR. High prevalence of hypertriglyceridemia and apolipoprotein abnormalities in coronary artery disease. Br Heart J 1988;60: 397-403
30. Knöfler R, Nakano T, Nakajima K, Takada Y, Takada A. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro. Thromb Res 1995;78:161-171
31. Moyer MP, Tracy RP, Tracy PB, van Veer C, Sparks CE, Mann KG. Plasma lipoprotein support prothrombinase and other procoagulant enzymatic complexes. Arterioscler Thromb Vase Biol 1998;18:458-465
32. Silveira A, Karpe F, Johnsson H, Bauer KA, Hamsten A. In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the extrinsic coagulation pathway. Arterioscler Thromb Vase Biol 1996;16:1333-1339
33. Djurovic S, Schjetlein R, Wisloff F, Haugen G, Husby H, Berg K. Plasma concentrations of Lp(a) and TGF-beta 1 are altered in preeclampsia. Clin Genet 1997;52:371-376
34. Wang J, Mimuro S, Lahoud R, Trudinger B, Wang XL. Elevated levels of lipoprotein(a) in women with preeclampsia. Am J Obstet Gynecol 1998;178:146-149
35. Leerink CB, de Vries CV, van der Klis FR. Elevated levels of serum lipoprotein(a) and apolipoprotein(a) phenotype are not related to preeclampsia. Acta Obstet Gynaecol Scand 1997; 76:625-628
36. Sheppard BL, Bonnar J. The maternal blood supply to the placenta in pregnancy complicated by intrauterine fetal growth retardation. In: Kaufmann P, Miller RK, eds. Placental Vascularization and Blood Flow. New York: Plenum Medical Book Company; 1988:69-81
37. Laivuori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996;81:2908-2911
38. Stein JH, Rosenson RS. Treatment of severe hypertriglyceridemia lowers plasma viscosity. Atherosclerosis 1998;137:401-405
39. Harris WS, Rothrock DW, Fanning A, et al. Fish oils in hypertriglyceridemia: A dose response study. Am J Clin Nutrition 1990;51:399-406